Search results
Results from the WOW.Com Content Network
Fire blight, also written fireblight, is a contagious disease affecting apples, pears, and some other members of the family Rosaceae. It is a serious concern to apple and pear producers. It is a serious concern to apple and pear producers.
Apr. 17—MOSES LAKE — Frank Zhao, a professor of plant pathology at Washington State University, spoke at the April 4 Fire Blight Webinar hosted by Michigan State University, providing an ...
Initially copper sprays were used for fire blight control in the 1930s but this method had limited success. [24] In the 1950s streptomycin and oxytetracycline showed high success in controlling fire blight in comparison to copper. Since then streptomycin sprayed two to three times during blooming phase has become the treatment of choice.
Fire blight: the disease and its causative agent, Erwinia amylovora.:37–53. Erskine JM. 1973. Characteristics of Erwinia amylovora bacteriophage and its possible role in the epidemiology of fire blight. Canadian Journal of Microbiology; 19(7):837–845. Johnson KB, Stockwell VO. 1998. MANAGEMENT OF FIRE BLIGHT: A Case Study in Microbial Ecology.
In the 1950s, the antibiotic streptomycin was used extensively to control the spread of Xanthomonas campestris pv. vesicatoria. However, the bacteria developed resistant strains and widespread antibiotic application is no longer an effective method of control. [9] It was once believed that a single strain of Xanthomonas campestris pv.
For premium support please call: 800-290-4726 more ways to reach us
Plague (Yersinia pestis): Has historically been used as the first-line treatment. However streptomycin is approved for this purpose only by the US Food and Drug Administration. [medical citation needed] In veterinary medicine, streptomycin is the first-line antibiotic for use against gram negative bacteria in large animals (horses, cattle ...
The discovery of streptomycin, an antituberculosis antibiotic, earned Selman Waksman the Nobel Prize in 1952. [19] The award was not without controversy, since it excluded the nomination of Albert Schatz , who is now recognized as one of the major co-inventors of streptomycin.